Humalog

Primary Uses

Humalog is a fast-acting insulin used to treat high blood sugar in people with diabetes. It works by replacing the insulin the body would normally produce and helping move sugar from the blood into other body tissues to be used for energy.

Type 1 and Type 2 Diabetes

• Type 1 Diabetes: Humalog is used in both adults and children to manage blood sugar levels.
• Type 2 Diabetes: Humalog is used in adults to help control blood sugar.

Mealtime Blood Sugar Management

This medication is specifically designed to control the rise in blood sugar that happens after eating. Because it begins working very quickly, it is typically taken shortly before or immediately after a meal. It is often used as part of a treatment plan that includes a longer-acting insulin to maintain stable blood sugar levels throughout the day and night.

Mechanism of Action

Humalog is a fast-acting insulin analog, which is a man-made version of the insulin naturally produced by the pancreas. It works by replacing or supplementing the body's own insulin to manage blood sugar levels in people with diabetes.

Regulating Blood Sugar

This medication works in several ways to control glucose levels:

• Glucose Absorption: It helps muscle and fat cells absorb sugar from the blood, which the body then uses for energy.
• Liver Regulation: It signals the liver to stop releasing stored sugar into the bloodstream.

Speed and Timing

Humalog is designed to work more quickly than regular human insulin. Because the body absorbs it rapidly after an injection, it starts to lower blood sugar within approximately 15 minutes. This fast onset makes it effective for managing the rise in blood sugar that occurs after eating a meal. The effects typically peak between 30 and 90 minutes after use and last for about 2 to 5 hours.

Common Side Effects

The most frequent side effects associated with Humalog include:

• Redness, swelling, or itching at the injection site.
• Changes in skin texture where the medication is injected, such as thickening or pits (lipodystrophy).
• Weight gain.
• Mild rash or itching.

Serious Side Effects

Some side effects can be serious and require immediate medical attention:

• Low blood sugar (hypoglycemia): This is the most common serious side effect. Symptoms include dizziness, sweating, confusion, headache, blurred vision, slurred speech, shakiness, or a fast heartbeat.
• Low potassium (hypokalemia): Symptoms may include muscle cramps, weakness, or an abnormal heart rhythm.
• Severe allergic reactions: Seek emergency care for a whole-body rash, shortness of breath, wheezing, fast pulse, or swelling of the face, lips, or throat.
• Heart failure: When used with certain other diabetes medications called thiazolidinediones (TZDs), Humalog may increase the risk of heart failure. Symptoms include shortness of breath, swelling of the ankles or feet, or sudden weight gain.

Hypoglycemia

Low blood sugar (hypoglycemia) is the most common side effect of insulin therapy and can be life-threatening. The risk increases with changes in meal patterns, physical activity, or the use of other medications. Severe hypoglycemia can cause seizures, loss of consciousness, or death. Monitoring blood glucose is essential for all patients using insulin.

Hypokalemia

All insulin products, including Humalog, cause a shift in potassium from the blood into the cells. This can lead to low potassium levels (hypokalemia). If left untreated, this may cause respiratory paralysis, heart rhythm problems, or death. Monitoring potassium levels may be necessary for patients at risk.

Allergic Reactions

Severe, life-threatening, generalized allergy, including anaphylaxis, can occur with Humalog. Localized reactions such as redness, swelling, or itching at the injection site are also possible. If a serious reaction occurs, the medication should be discontinued and medical help sought immediately.

Heart Failure Risk

Fluid retention and heart failure can occur when using Humalog in combination with certain other diabetes medications called thiazolidinediones (TZDs). Patients should be monitored for signs of heart failure, such as shortness of breath, sudden weight gain, or swelling of the ankles and feet.

Medication Errors and Safety

Accidental mix-ups between Humalog and other insulins have been reported. It is important to check the insulin label before each injection to ensure the correct type and strength are used. Additionally, insulin pens and needles must never be shared between patients, even if the needle is changed, as this increases the risk of spreading bloodborne pathogens.

Renal and Hepatic Impairment

Patients with kidney or liver problems may require more frequent blood glucose monitoring and dose adjustments, as these conditions can change how the body processes insulin.

Pregnancy

Maintaining blood glucose control is vital for the health of both the mother and the developing fetus. Humalog is commonly used during pregnancy, and clinical data have not shown an increased risk of birth defects or other complications compared to other insulin types.

Insulin requirements often fluctuate during pregnancy. It is common for insulin needs to decrease during the first trimester and increase during the second and third trimesters. Frequent monitoring and dosage adjustments by a healthcare professional are standard practice during this time.

Breastfeeding

Humalog is generally considered safe to use while breastfeeding. Insulin is a natural component of breast milk, and exogenous insulin like Humalog is not expected to harm a nursing infant. However, breastfeeding may affect blood sugar levels, and some individuals may require adjustments to their insulin dose or meal plan while nursing.

Available Forms

Humalog is a fast-acting insulin solution administered by injection. It is available in several delivery formats to accommodate different administration needs:

• Vials: These are used with traditional insulin syringes or compatible external insulin pumps.
• Prefilled Pens: These are disposable, single-patient-use devices and include the KwikPen, Junior KwikPen, and Tempo Pen.
• Cartridges: These are designed for use with specific reusable insulin delivery pens.

The medication is typically administered as a subcutaneous injection under the skin. In specific medical environments, it may also be administered as an intravenous infusion under the supervision of a healthcare professional.

FDA Approval and Indications

Humalog (insulin lispro) was first approved by the U.S. Food and Drug Administration (FDA) in 1996. It was the first rapid-acting insulin analog available for the treatment of diabetes mellitus. It is indicated for use in both adults and children to manage blood glucose levels and is typically used in combination with a longer-acting insulin.

Safety and Regulatory Monitoring

The FDA monitors the safety of Humalog through the Adverse Event Reporting System (FAERS). In 2018, the FDA identified potential signals of serious risk regarding medication errors involving various insulin products, including Humalog. This led to the identification of a need for updated safety information and clearer labeling to help prevent confusion between different insulin types and strengths.

Prescription Status

Humalog is a prescription-only medication. While the FDA has approved follow-on versions of insulin lispro that are biologically similar to Humalog, it remains a primary brand-name reference product for rapid-acting insulin therapy.

Type and Action

Humalog is a rapid-acting insulin. It is a man-made version of the insulin the body naturally produces, but it has been slightly changed so that it can be absorbed into the bloodstream more quickly than regular human insulin.

How It Works

Humalog helps manage blood sugar by performing the same tasks as natural insulin:

• It helps move sugar from the blood into the body's cells, where it is used for energy.
• It stops the liver from making and releasing too much sugar into the blood.

Timing and Use

Because it is rapid-acting, Humalog has a specific timeline for its effects:

• Onset: It usually starts working within 15 minutes after it is injected.
• Peak: It is most effective between 30 and 90 minutes after injection.
• Duration: It continues to work for about 3 to 5 hours.

Humalog is typically taken shortly before or just after a meal to handle the rise in blood sugar that happens when you eat. It is often used along with a long-acting insulin that provides a steady level of insulin throughout the day and night. It can be given by injection under the skin or through an external insulin pump.